AU2001285633A1 - Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections - Google Patents

Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections

Info

Publication number
AU2001285633A1
AU2001285633A1 AU2001285633A AU8563301A AU2001285633A1 AU 2001285633 A1 AU2001285633 A1 AU 2001285633A1 AU 2001285633 A AU2001285633 A AU 2001285633A AU 8563301 A AU8563301 A AU 8563301A AU 2001285633 A1 AU2001285633 A1 AU 2001285633A1
Authority
AU
Australia
Prior art keywords
haemophilus influenzae
lipopolysaccharide
vaccines
relates
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285633A
Other languages
English (en)
Inventor
Andrew Cox
Derek Hood
Martin Manson
Richard Moxon
James C. Richards
Elke K. H. Schweda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
AVENTIS PASTEUR
Aventis Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AVENTIS PASTEUR, Aventis Pasteur Ltd filed Critical AVENTIS PASTEUR
Publication of AU2001285633A1 publication Critical patent/AU2001285633A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001285633A 2000-08-25 2001-08-27 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections Abandoned AU2001285633A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22785000P 2000-08-25 2000-08-25
US60/227,850 2000-08-25
PCT/CA2001/001225 WO2002016440A2 (en) 2000-08-25 2001-08-27 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections

Publications (1)

Publication Number Publication Date
AU2001285633A1 true AU2001285633A1 (en) 2002-03-04

Family

ID=22854724

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285633A Abandoned AU2001285633A1 (en) 2000-08-25 2001-08-27 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections

Country Status (9)

Country Link
US (1) US7364739B2 (de)
EP (1) EP1313771B1 (de)
JP (1) JP2004506086A (de)
AT (1) ATE357461T1 (de)
AU (1) AU2001285633A1 (de)
CA (1) CA2420477A1 (de)
DE (1) DE60127421T8 (de)
ES (1) ES2284681T3 (de)
WO (1) WO2002016440A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020059A2 (en) * 2000-09-01 2002-03-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
EP1747262B1 (de) * 2004-05-14 2012-09-26 National Research Council Of Canada Konservierte innerer-kern-lipopolysaccharid-epitope als impfstoffkandidaten für mehrere spezies
US8795680B2 (en) * 2006-07-21 2014-08-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid
JP2008125425A (ja) * 2006-11-20 2008-06-05 Osaka Univ 核酸の増幅反応に用いる繰返し配列結合プライマー及びその利用
WO2008106763A1 (en) * 2007-03-08 2008-09-12 The Governors Of The University Of Alberta Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
WO2016007891A1 (en) * 2014-07-10 2016-01-14 University Of Iowa Research Foundation Vaccine for nontypeable haemophilus influenzae

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0681026A1 (de) 1987-03-02 1995-11-08 Whitehead Institute For Biomedical Research Rekombinant-mykobakterielle Impfstoffe
US5504005A (en) 1987-03-02 1996-04-02 Albert Einstein College Of Medicine Of Yeshiva University Recombinant mycobacterial vaccine
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
ZA894589B (en) * 1989-02-09 1991-02-27 K Sudan Krishan Semi-flexible or flexible phenolic foam
CA2076753A1 (en) 1990-02-26 1991-08-27 Anthony J. Radford Shuttle plasmid for escherichia coli and mycobacteria
GB9015888D0 (en) 1990-07-19 1990-09-05 Smithkline Biolog Vectors
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
CA2097931C (en) 1990-12-18 2003-07-29 Samuel I. Miller, Iii Salmonella vaccines
WO1992021376A1 (en) 1991-06-06 1992-12-10 Med Immune, Inc. Induction of ctl responses to foreign antigens expressed in mycobacteria
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
DE69434469T2 (de) 1993-01-26 2006-06-14 Univ Pennsylvania Zusammensetzungen und verfahren zur verabreichung von genetischem material
GB9326174D0 (en) 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US20030072774A1 (en) 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants
US6019982A (en) 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
US5527928A (en) * 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
US6207157B1 (en) * 1996-04-23 2001-03-27 The United States Of America As Represented By The Department Of Health And Human Services Conjugate vaccine for nontypeable Haemophilus influenzae
CA2264970A1 (en) 1998-03-10 1999-09-10 American Cyanamid Company Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
DE19844191A1 (de) * 1998-09-28 2000-03-30 Pharma Zentrale Gmbh Lipopolysaccharide aus Escherichia coli
CA2355292C (en) * 1998-12-15 2007-02-06 Exiqon A/S Coupling of lipopolysaccharide-derived carbohydrates onto solid surfaces
JP2004520001A (ja) * 1999-05-18 2004-07-08 ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン 複合糖質の製造

Also Published As

Publication number Publication date
JP2004506086A (ja) 2004-02-26
ES2284681T3 (es) 2007-11-16
WO2002016440A2 (en) 2002-02-28
DE60127421T2 (de) 2007-11-29
CA2420477A1 (en) 2002-02-28
WO2002016440A9 (en) 2004-05-13
EP1313771A2 (de) 2003-05-28
ATE357461T1 (de) 2007-04-15
WO2002016440A8 (en) 2002-11-14
DE60127421T8 (de) 2008-08-28
DE60127421D1 (de) 2007-05-03
EP1313771B1 (de) 2007-03-21
WO2002016440A3 (en) 2002-06-06
US20050153057A1 (en) 2005-07-14
US7364739B2 (en) 2008-04-29

Similar Documents

Publication Publication Date Title
MA30065B1 (fr) Vaccin
WO2000056360A3 (en) Vaccine against antigens from bacteriae
WO2002091998A3 (en) Novel meningitis conjugate vaccine
MXPA03008154A (es) Novedoso adyuvante de vacuna de proteosoma-liposacarido.
AU8483391A (en) Improved oligosaccharide conjugate vaccines
LU91924I2 (fr) Composition vaccinale comprenant le polysaccharidecapsulaire et Haemophilus influenzae type b coupl é à l'anatoxine tétanique, l'antigène diphtérique,l'antigène tétanique, des antigènes de la polio, des antigènes de la coqueluche et du phosphate d'aluminium
HUP0301413A1 (hu) Vakcinakészítmények
WO2004110480A3 (en) Polyanionic polymer adjuvants for haemophilus influenza b saccharide vaccines
WO2004041157A3 (en) Group b streptococcus vaccine
WO2003094834A3 (en) Mucosal vaccines with chitosan adjuvant and meningococcal antigens
WO2004080490A3 (en) Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
WO2010141312A3 (en) Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
PT786518E (pt) Vacina contra streptococus equi
AU2003206532A1 (en) Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
AU2001285633A1 (en) Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
MY125000A (en) Novel compositions
WO1999052548A3 (en) Conjugate vaccines for the prevention of dental caries
WO2001078787A3 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment